Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of the ADRA2A C1291G genetic polymorphism in response to dexmedetomidine on patients undergoing coronary artery surgery.

Molecular biology reports - 1 Jun 2011

Yağar Seyhan, Yavaş Soner, Karahalil Bensu

Abstract excerpt

The existence of interindividual drug response variability has been known for a long time. Individual susceptibility which might cause toxicity or inadequate treatment is important in drug therapy. Genetic polymorphisms in genes responsible for drug response are expected to be useful in keeping track of differences among individuals. Dexmedetomidine is a sedative drug, whose use in intensive care unit patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coronary Artery Bypass
Share to Coronary Vessels

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Hemodynamics

Share to Hypnotics and Sedatives

Share to Polymorphism, Genetic

Share to Polymorphism, Restriction Fragment Length

Share to Receptors, Adrenergic, alpha-2

Source

Identifiers

PMID: 21104443
DOI: 10.1007/s11033-010-0446-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of the ADRA2A C1291G genetic polymorphism in response to dexmedetomidine on patients undergoing coronary artery surgery.PMID 21104443Read ↗

The effect of alpha-2A adrenergic receptor (ADRA2A) genetic polymorphisms on the depth of sedation of dexmedetomidine: a genetic observational pilot study.Semantic proximity Read ↗

Genetic variations in the α(2A)-adrenoreceptor are associated with blood pressure response to the agonist dexmedetomidine.Semantic proximity Read ↗

A pilot study of ADRA2A genotype association with doses of dexmedetomidine for sedation in pediatric patients.Semantic proximity Read ↗

beta2 adrenoceptor (ADRB2) pharmacogenetics and cardiovascular phenotypes during laryngoscopy and tracheal intubation.Semantic proximity Read ↗

Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline.Semantic proximity Read ↗

Genetic polymorphisms are associated with individual susceptibility to dexmedetomidineSemantic proximity Read ↗

[Pharmacogenetical aspects of clinical anaesthesiology].Semantic proximity Read ↗

Effects of Dexmedetomidine and ACE Genotype on Cardiovascular Response During the Decannulation Period of General Anesthesia in Patients With Essential Hypertension.Semantic proximity Read ↗

The alpha 2A-adrenergic receptor gene polymorphism modifies antidepressant responses to milnacipran.Semantic proximity Read ↗

Ethnic and genetic determinants of cardiovascular response to the selective alpha 2-adrenoceptor agonist dexmedetomidine.Semantic proximity Read ↗

The effects of beta2 adrenoceptor gene polymorphisms on pressor response during laryngoscopy and tracheal intubation.Semantic proximity Read ↗

Assessment of ADRB1 polymorphism in patients with acute coronary syndrome treated with ticagrelor and aspirin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.